Skip Navigation

European Heart Journal 2001 22(8):712-713; doi:10.1053/euhj.2001.2403
Copyright © 2001 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Murray, R.D.
Right arrow Articles by Klein, A.L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Murray, R.D.
Right arrow Articles by Klein, A.L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Letters to the Editor

Use of low-molecular-weight heparin as bridge anticoagulation therapy in patients with atrial fibrillation undergoing transoesophageal echocardiography guided cardioversion

R.D. Murraya, S.R. Deitcherb and A.L. Kleina

a Department of Cardiology, Cleveland Clinic Foundation, Cleveland, Ohio, U.S.A.
b Deaprtment of Vascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, U.S.A.

References

  1. Roijer A, Eskilsson J, Olsson B. Transesophageal echocardiography-guided cardioversion of atrial fibrillation or flutter. Eur Heart J. 2000;21:837–847[Abstract/Free Full Text]
  2. Stellbrink C, Hanrath P. The optimal management of cardioversion of atrial fibrillation or flutter: still a ‘stunning’ problem. Eur Heart J. 2000;21:795–798[Free Full Text]
  3. Klein AL, Grimm RA, Black IW. Transesophageal echocardiographic-guided cardioversion: a randomized controlled clinical trial—The ACUTE pilot study. Ann Intern Med. 1997;126:200–209[Abstract/Free Full Text]
  4. Am J Cardiol. 1998;81:877–883[CrossRef][ISI][Medline]
  5. ACUTE Investigators, Transesophageal echocardiography guided cardioversion of patients in atrial fibrillation undergoing cardioversion: eight-week clinical outcomes, 2000
  6. Murray RD, Shah A, Jasper SE. Design of a pilot study to test the feasibility, general safety, and economics of a transesophageal echocardiography guided low molecular weight heparin (enoxaparin) approach to cardioversion of patients in atrial fibrillation: The ACUTE II Study. Am Heart J. 2000;139:e5[CrossRef]
  7. Murray RD, Deitcher S, Shah A. Potential clinical efficacy and cost benefit of a TEE guided low molecular weight heparin approach to antithrombotic therapy in patients undergoing immediate cardioversion from atrial fibrillation. J Am Soc Echocardiogr. 2000;:

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Murray, R.D.
Right arrow Articles by Klein, A.L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Murray, R.D.
Right arrow Articles by Klein, A.L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?